These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 16515684)

  • 1. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
    Kolaczynska KE; Thomann J; Hoener MC; Liechti ME
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.
    Verrico CD; Lynch L; Fahey MA; Fryer AK; Miller GM; Madras BK
    J Psychopharmacol; 2008 Mar; 22(2):187-202. PubMed ID: 18308800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
    Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
    Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
    Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
    Simmler LD; Liechti ME
    Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters.
    Pifl C; Nagy G; Berényi S; Kattinger A; Reither H; Antus S
    J Pharmacol Exp Ther; 2005 Jul; 314(1):346-54. PubMed ID: 15831439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
    Brandt SD; Walters HM; Partilla JS; Blough BE; Kavanagh PV; Baumann MH
    Psychopharmacology (Berl); 2020 Dec; 237(12):3703-3714. PubMed ID: 32875347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.
    Del Bello F; Sakloth F; Partilla JS; Baumann MH; Glennon RA
    Bioorg Med Chem; 2015 Sep; 23(17):5574-9. PubMed ID: 26233799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
    Madras BK; Xie Z; Lin Z; Jassen A; Panas H; Lynch L; Johnson R; Livni E; Spencer TJ; Bonab AA; Miller GM; Fischman AJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):561-9. PubMed ID: 16885432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca
    Ruchala I; Battisti UM; Nguyen VT; Chen RY; Glennon RA; Eltit JM
    Toxicol Appl Pharmacol; 2021 May; 419():115513. PubMed ID: 33785354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR.
    Rickli A; Kolaczynska K; Hoener MC; Liechti ME
    Neurotoxicology; 2019 May; 72():95-100. PubMed ID: 30776375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
    Siebert GA; Pond SM; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells.
    Bryan-Lluka LJ; Siebert GA; Pond SM
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):109-15. PubMed ID: 10494878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.